Project Title: Development of a Transcatheter Blood Pump System for Cardiogenic Shock and Hemodynamically Compromised Patients (Project SAVA)
VenstraMedical, an Australian company based in Newcastle, is developing a percutaneous ventricular assist device (pVAD). This is a small blood pump placed at a catheter tip, implanted by a cardiologist into the patient’s heart, to provide temporary cardiac support.
This device will treat patients at high risk due to cardiogenic shock or who are undergoing high risk coronary interventions. It will address significant unmet needs for critically ill patients that are currently underserved due to the cost and invasiveness of current pVAD systems. This next generation device aims to provide full cardiac support and be small enough for rapid non-surgical implantation, supporting use in emergency situations.
The goal of this project is to complete animal studies with the complete system, including the external console and drive system.
BMTH Round: Three
State: New South Wales
- MTPConnect Grant: $850,000
- Industry Contribution: $56,000
Duration: October 2020 - September 2022
Visit VenstraMedical for more information
Contact Project Lead: Dr Suku Thumbar